Locus Capital Partners (Locus), a M&A advisory firm, is pleased to announce the Completion of Inscobee’s issuance of convertible bonds to domestic investors. Locus advised Inscobee in this debt offering.

Founded in 1970, Inscobee is a KOSPI-listed network management solution provider that also engages in bio research business covering medicines, vaccines for cervical cancer, papillomavirus, cosmeceuticals and nutraceuticals. Inscobee is seeking to use the funds into expanding its bio business.

Locus acted as an exclusive financial advisor to Inscobee by managing and executing the entire debt offering process together with accounting, tax, and legal advisors.